Earlier Repletion of Lymphocytes After Alemtuzumab Induction Is Associated with a Lower Incidence of Infection Following Renal Transplantation.

被引：0
|
作者：
Willicombe, M. [1 ]
Goodall, D. [1 ]
McLean, A. [1 ]
Taube, D. [1 ]
机构：
[1] Hammersmith Hosp, Imperial Coll, Renal & Transplant Ctr, London, England
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2016年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
223
引用
收藏
页码：282 / 282
页数：1
相关论文
共 50 条
  • [1] Correlation of Recipient Factors with the Course of Lymphocytes after Alemtuzumab Induction in Renal Transplantation.
    Weissenbacher, A.
    Kimelman, M.
    Hautz, T.
    Ulmer, H.
    Boesmueller, C.
    Maglione, M.
    Margreiter, R.
    Oellinger, R.
    Pratschke, J.
    Schneeberger, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 316 - 316
  • [2] Allograft Failure After Alemtuzumab Induction in Renal Transplantation.
    Willicombe, M.
    Goodall, D.
    Charif, R.
    Galliford, J.
    McLean, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 581 - 581
  • [3] Allograft Failure After Alemtuzumab Induction in Renal Transplantation.
    Willicombe, M.
    Goodall, D.
    Charif, R.
    Galliford, J.
    McLean, A.
    Taube, D.
    TRANSPLANTATION, 2014, 98 : 581 - 581
  • [4] Alemtuzumab Induction as a Mediator of Nonadherence in Renal Transplantation.
    Mitro, G.
    Ekwenna, O.
    Rees, M.
    Ortiz, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 778 - 778
  • [5] Alemtuzumab Induction in Living Donor Renal Transplantation.
    Witkowsky, O.
    Winters, H.
    Washburn, K.
    Bumgardner, G.
    Rajab, A.
    El-Hinnawi, A.
    Pesavento, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 816 - 817
  • [6] Thrombocytopenia after Alemtuzumab Induction in Kidney Transplantation.
    Chan, K.
    Tanna, A.
    Charif, R.
    Cairns, T.
    Duncan, N.
    Galliford, J.
    Kumar, N.
    McLean, A.
    Palmer, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 431 - 431
  • [7] Tacrolimus Weaning Is Not Necessary after Alemtuzumab Induction in Live Related Renal Transplantation.
    Chan, K.
    Galliford, J.
    Charif, R.
    Cook, T.
    Chusney, G.
    Goodall, D.
    Roufosse, C.
    McLean, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 675 - 675
  • [8] CORRELATION OF RECIPIENT FACTORS WITH THE COURSE OF LYMPHOCYTES AFTER ALEMTUZUMAB INDUCTION IN RENAL TRANSPLANTATION
    Weissenbacher, A.
    Kimelman, M.
    Hautz, T.
    Ulmer, H.
    Boesmueller, C.
    Maglione, M.
    Margreiter, R.
    Oellinger, R.
    Pratschke, J.
    Schneeberger, S.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 53 - 53
  • [9] Correlation of Recipient Factors with the Course of Lymphocytes after Alemtuzumab Induction in Renal Transplantation
    Weissenbacher, A.
    Kimelman, M.
    Hautz, T.
    Ulmer, H.
    Boesmueller, C.
    Maglione, M.
    Margreiter, R.
    Oellinger, R.
    Pratschke, J.
    Schneeberger, S.
    TRANSPLANTATION, 2012, 94 (10) : 984 - 984
  • [10] Low Incidence of NODAT with Alemtuzumab Induction and Tacrolimus Monotherapy without Steroids and MMF in Renal Transplantation.
    Chan, K.
    Lawrence, C.
    Charif, R.
    McLean, A.
    Cairns, T. D. H.
    Duncan, N.
    Goodall, D.
    Palmer, A.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 513 - 513
12345